Bioventus BVS Income Statement (2020-2026)

NASDAQ BVS
$13.64 -0.19 (-1.41%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Bioventus Quarterly Income Statement

Periods 26 quarters
Latest Jun 2026

Bioventus reported revenue of $153.21M and net income of $37.38M for the quarter ended Jun 2026, up 3.8% year over year. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Apr2021 Jul2021 Oct2021 Dec2021 Apr2022 Jul2022 Oct2022 Dec2022 Apr2023 Jul2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
108.89M130.41M117.29M140.33M128.66M125.83M119.06M137.07M120.79M135.42M129.46M151.22M138.96M153.64M123.88M147.66M138.65M157.90M132.09M153.21M
Cost of RevenueCost of Rev
29.82M42.65M41.59M43.68M44.13M51.65M45.14M47.95M41.94M49.12M41.08M47.58M45.41M50.99M40.82M45.57M44.42M49.12M41.32M47.54M
Gross Profit
79.07M87.77M75.70M96.65M84.53M74.19M73.92M89.12M78.85M86.30M88.38M103.64M93.55M102.66M83.06M102.09M94.23M108.78M90.77M105.67M
Operating items
Research & DevelopmentR&D
6.15M7.10M6.93M6.37M4.61M5.95M3.77M3.40M3.02M3.26M2.63M4.21M3.84M3.27M3.01M3.17M2.92M3.01M2.47M3.17M
Selling, General & AdministrativeSG&A
69.64M80.88M86.12M89.62M78.95M77.44M80.86M74.84M69.82M78.36M78.78M96.67M81.48M86.87M73.50M79.11M78.66M82.76M78.33M82.74M
Restructuring CostsRestructuring
1.80M0.69M0.58M1.01M0.57M4.62M0.32M0.62M-0.03M-0.07M-0.05M0.45M-0.41M
Other Operating ExpensesOther Opex
-0.98M-1.40M-1.20M-0.29M-0.08M-0.00M0.00M
Operating ExpensesOpex
77.59M88.67M93.63M96.99M84.14M88.00M84.95M78.86M72.81M81.55M81.40M100.88M85.33M90.09M76.51M82.28M81.58M85.76M81.25M85.50M
Operating IncomeOp. Inc
-1.05M-3.15M-21.45M-3.31M-126.84M-15.64M-92.06M6.75M2.42M1.17M4.93M-31.47M3.65M7.70M4.87M18.37M11.25M19.49M8.42M19.13M
EBIT
-1.05M-3.15M-21.45M-3.31M-126.84M-15.64M-92.06M6.75M2.42M1.17M4.93M-31.47M3.65M7.70M4.87M18.37M11.25M19.49M8.42M19.13M
Non-operating items
Non Operating Interest Expenses
Interest & Investment IncomeInt & Inv Inc
-1.35M-0.96M1.55M-2.58M-3.60M-7.39M-9.69M-10.59M-10.12M-10.28M-10.34M-9.92M-9.53M-9.00M-7.51M-7.49M-6.18M-5.31M-4.33M-4.07M
Other Non Operating IncomeOther Non Op Inc.
-0.76M1.36M0.36M-0.60M-0.12M-9.41M1.59M-0.51M-0.49M0.71M-0.06M-0.16M0.63M1.24M-0.78M-0.56M-0.79M-0.04M1.00M0.93M
Non Operating IncomeNon Op. Inc.
-2.10M0.40M1.91M-3.18M-3.72M-16.80M-8.11M-11.10M-10.61M-9.57M-10.40M-10.08M-8.91M-7.76M-8.29M-8.05M-6.58M-5.34M-3.90M-3.82M
Net income details
EBT
-3.15M-2.75M-19.54M-6.49M-130.56M-32.44M-100.16M-4.35M-8.19M-8.41M-5.47M-41.56M-5.26M-0.05M-3.42M10.31M4.67M14.14M4.52M15.31M
Tax ProvisionsTaxes
-0.88M-2.73M-5.13M1.24M-29.52M-10.96M-0.15M0.38M0.60M-0.75M0.91M-7.34M0.59M0.55M-0.10M1.04M0.66M-3.17M0.57M-20.90M
Profit After TaxPAT
-2.63M-1.89M-15.09M-8.24M-145.70M-45.24M-174.45M-4.73M-9.12M-7.66M-6.97M-34.64M-5.85M-4.35M-3.32M10.87M4.01M17.24M3.95M37.38M
Income from Non-Controlling InterestsInc. Minority
-1.30M-1.53M-3.53M-0.76M-28.20M-8.24M-20.36M-1.05M-1.49M-1.56M-1.49M-8.62M-0.68M-0.13M-0.69M2.12M0.85M2.39M0.83M2.98M
Income from Continuing OperationsIncome (Continuing)
-2.27M-0.03M-14.40M-7.73M-101.03M-21.48M-100.02M-4.73M-8.79M-7.66M-6.38M-34.22M-5.85M-0.60M-3.32M9.27M4.01M17.32M3.95M36.20M
Income from Discontinued OperationsIncome (Discontinued)
-0.40M-0.28M-44.66M-23.40M-74.43M
Consolidated Net IncomeConsol Net Inc.
-2.27M-0.03M-14.81M-8.01M-145.70M-44.87M-174.45M-4.73M-8.79M-7.66M-6.38M-34.22M-5.85M-0.60M-3.32M9.27M4.01M17.32M3.95M36.20M
Income towards Parent CompanyParent Net Inc
-2.27M-0.03M-14.81M-8.01M-145.70M-44.87M-174.45M-4.73M-8.79M-7.66M-6.38M-34.22M-5.85M-0.60M-3.32M9.27M4.01M17.32M3.95M36.20M
Net Income towards Common StockholdersNet Income
-2.27M-0.03M-14.81M-8.01M-145.70M-44.87M-174.45M-4.73M-8.79M-7.66M-6.38M-34.22M-5.85M-0.60M-3.32M9.27M4.01M17.32M3.95M36.20M
Additional items
EPS (Basic)
-0.050.00-0.24-0.13-2.36-0.73-2.81-0.08-0.14-0.12-0.10-0.53-0.09-0.01-0.050.140.060.260.060.53
EPS (Diluted)
-0.050.00-0.24-0.13-2.36-0.73-2.81-0.08-0.14-0.12-0.10-0.53-0.09-0.01-0.050.140.060.250.060.51
Shares Outstanding
41.84M45.47M60.48M61.48M61.67M61.39M62.12M62.55M62.82M62.65M63.38M64.06M65.26M64.55M66.01M66.50M66.92M66.62M67.30M67.87M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
41.84M45.47M60.48M61.48M61.67M61.39M62.12M62.55M62.82M62.65M63.38M64.06M65.26M64.55M66.01M68.54M68.84M68.91M70.01M70.84M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
56.88M75.34M77.14M77.44M77.56M77.85M78.29M78.59M78.75M79.05M79.61M80.96M81.15M81.55M82.02M82.67M82.76M82.88M83.43M84.00M
EBITDA
-1.05M-3.15M-21.45M-3.31M-126.84M-15.64M-92.06M6.75M2.42M1.17M4.93M-31.47M3.65M7.70M4.87M18.37M11.25M19.49M8.42M19.13M
Interest ExpensesInt Expense
Tax Rate
27.99%99.09%26.27%-19.17%22.61%33.79%0.15%-8.76%-7.33%8.92%-16.57%17.66%-11.20%-1,037.74%2.78%10.09%14.22%-22.45%12.64%-136.51%